Concerning the effects of n-3 PUFA on Foxo1, eicosapentaenoic acid (EPA) supplementation decreased hepatic steatosis and lowered hepatic FOXO1 protein expression in young Zucker rats [34]. Here, FOXO1 is linked to fatty liver disease.